FI105024B - Förfarande för framställning av terapeutiskt användbara N-(amidinobensoyl- eller amidinopyridylkarbonyl)-alfa-aminosyraderivat - Google Patents
Förfarande för framställning av terapeutiskt användbara N-(amidinobensoyl- eller amidinopyridylkarbonyl)-alfa-aminosyraderivat Download PDFInfo
- Publication number
- FI105024B FI105024B FI921163A FI921163A FI105024B FI 105024 B FI105024 B FI 105024B FI 921163 A FI921163 A FI 921163A FI 921163 A FI921163 A FI 921163A FI 105024 B FI105024 B FI 105024B
- Authority
- FI
- Finland
- Prior art keywords
- acid
- acetic acid
- piperidinyl
- oxy
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Saccharide Compounds (AREA)
- Gas Burners (AREA)
- Cephalosporin Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Claims (16)
1. Förfarande för framställning av terapeutiskt an-vändbara N- (amidinobensoyl- eller amidinopyridylkarbonyl) -5 α-aminosyraderivat med formeln I HaN>. ___ O R" j^\ n i i X = Y R· S
2. Förfarande enligt patentkrav 1, k ä n n e -tecknat av att man framställer [[1-(N-(p-amidino-30 bensoyl)-L-alanyl]-4-piperidinyl]oxi]attiksyra. · 3. Förfarande enligt patentkrav l, kanne- tecknat av att man framställer [[1—[N—[(5-amidino- 2-pyridyl) karbonyl] -L-alanyl] - 4-piperidinyl ] oxi ] ättiksyra. • · 60 105024
3. X=Y R· J) « · A 59 105024 omvandlas cyangruppen till en amidinogrupp pä ett i och för sig känt sätt, eller c) en amin med formeln
4. Förfarande enligt patentkrav 1, kanne- tecknat av att man framställer [[1-[N-(p-amidi-nobensoyl)-3-(4-hydroxi-3-jodfenyl)-L-alanyl]-4-piperidinyl] oxi]ättiksyra. 5 5. Förfarande enligt patentkrav 1, k ä n n e - tecknat av att man framställer [[1-[3-acetoxi-N-(p-amidinobensoyl)-L-alanyl]-4-piperidinyl]oxi]ättiksyra.
5 R'-NHCH(R")CO-Q IV omsätts med en syra med formeln XIII 10 \-COOH XUI HN ' eller ett reaktivt derivat därav pä ett i och för sig känt sätt, 15 och eventuellt underkastas den erhällna föreningen med formeln I en eller flera av följande reaktioner: i) en primär eller sekundär lägre alkoxikarbonyl-grupp eller fenyl-lägre-alkoxikarbonylgrupp -COOT eller -COOT' spjälkas till en fri karboxylgrupp, 20 ii) en karboxylgrupp -COOT eller -COOT' förestras till en primär eller sekundär lägre alkoxikarbonylgrupp eller fenyl-lägre-alkoxikarbonylgrupp, iii) en fenylgrupp i gruppen R" joderas, iv) en förening med formeln I omvandlas till ett 25 fysiologiskt användbart salt, och v) ett salt av en förening med formeln I omvandlas till en fri syra eller bas.
6. Förfarande enligt patentkrav 1, k ä n n e - tecknat av att man framställer [p-[[1-(p-amidino- 10 bensoyl)-2-pyrrolidinyl]karbonyl]fenoxi]ättiksyra.
7. Förfarande enligt patentkrav 1, k ä n n e - tecknat av att man framställer [[1-[N-[(5-amidino-2-pyridyl)karbonyl]-L-tyrosyl]-4-piperidinyl]oxi]ättiksyra. 15
8. Förfarande enligt patentkrav 1, kanne- tecknat av att man framställer [[1-[N-(p-amidino-bensoyl)-L-tyrosyl]-4-piperidinyl]oxi]ättiksyra.
9. Förfarande enligt patentkrav 1, k ä n n e - tecknat av att man framställer (S)-1-[2-(5-amidino- 20 pyridin-2-ylkarbonylamino)-3-(4-metoxifenyl)propionyl]pi pe r idin- 4 -yloxi ättiksyra .
10. Förfarande enligt patentkrav 1, k ä n n e -tecknat av att man framställer (S)-1-[2-(4-amidino-bensamido) -3- (4-metoxifenyl) propionyl ] piperidin-4-yloxiät- 25 tiksyraetylester.
10 HN väri den ena av X och Y är CH och den andra är CH eller N, R' är väte eller metyl,
15 R" är väte, lägre alkyl, fenyl eller lägre alkyl med en substituent ur gruppen hydroxi, lägre alkoxi, lägre alka-noyloxi, amino, karboxyl, fenyl, med lägre alkoxi, jod och/eller hydroxi substituerad fenyl och indolyl, eller R' och R" tillsammans med de N- och C-atomer, vid vilka de är 20 bundna, bildar en 5- eller 6-ledad ring, Q är en grupp med formeln: /(CHa)n-v o COO-T —N Y ^ , • \ / O 25 '-' eller * « eller, dä R' och R" tillsammans med de N- och C-atomer, vid vilka de är bundna, bildar en ring, sä kan Q ytterli-gare vara en grupp med formeln 58 105024 Rz '}==\ Q9 -(\ /)—O COO-T V 5 n är ett tai 0 eller 1, R2 betecknar väte eller en grupp -OCH2COO-T', T och Τ' betecknar väte, primär eller sekundär lägre alkyl 10 eller fenyl-lägre-alkyl, samt deras hydrater och solvater och deras fysiologiskt användbara salter, kännetecknatav att a) i en förening med formeln 15
0 E" f/ λ II I A (/ \ C-N-CH-C-G II \ / I II X = Y E' O 20 vari A är en eventuellt skyddad amidinogrupp, E', E" och G betecknar samma som R', R" respektive Q i formeln I, varvid G ändä i stället för gruppen -COOT inne-häller en tert-butoxikarbonylgrupp -COO-tBu och E' och E" I · 25 kan innehälla en karboxylsyraestergrupp och/eller eter- grupp och/eller skyddad aminogrupp, spjälkas den i G närvarande gruppen -COO-tBu och en eventuellt i A, E1 eller E" närvarande etergrupp, skyddad amino- eller amidinogrupp eller karboxylsyraestergrupp pä ett 30 i och för sig känt sätt, eller · b) i en nitril med formeln ___ O R" // \ « 1 TTT NsC—f x)-C-N-CH-C-Q 111
11. Förfarande enligt patentkrav 1, k ä n n e -tecknat av att man framställer (S)-1-[2-(4-amidino-bensamido) -3- (4-metoxifenyl) propionyl ]piperidin-4-yloxiät-tiksyra. 30
12. Förfarande enligt patentkrav 1, känne- t e c k n a t av att man framställer [l-[N-(4-amidino-bensoyl)-4 '-hexyloxi-L-fenylalanyl]piperidin-4-yloxi]ättiksyra . 4 . · ·
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH91091 | 1991-03-26 | ||
CH91091 | 1991-03-26 | ||
CH17692 | 1992-01-22 | ||
CH17692 | 1992-01-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI921163A0 FI921163A0 (fi) | 1992-03-18 |
FI921163A FI921163A (fi) | 1992-09-27 |
FI105024B true FI105024B (sv) | 2000-05-31 |
Family
ID=25683769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI921163A FI105024B (sv) | 1991-03-26 | 1992-03-18 | Förfarande för framställning av terapeutiskt användbara N-(amidinobensoyl- eller amidinopyridylkarbonyl)-alfa-aminosyraderivat |
Country Status (29)
Country | Link |
---|---|
US (4) | US5378712A (sv) |
EP (1) | EP0505868B1 (sv) |
JP (1) | JPH06102640B2 (sv) |
KR (1) | KR100254757B1 (sv) |
AT (1) | ATE127800T1 (sv) |
AU (1) | AU659629B2 (sv) |
BG (1) | BG60796B2 (sv) |
CA (1) | CA2061661A1 (sv) |
CZ (1) | CZ283508B6 (sv) |
DE (1) | DE59203619D1 (sv) |
DK (1) | DK0505868T3 (sv) |
DZ (1) | DZ1566A1 (sv) |
EE (1) | EE02982B1 (sv) |
ES (1) | ES2078570T3 (sv) |
FI (1) | FI105024B (sv) |
GR (1) | GR3018374T3 (sv) |
HK (1) | HK1003997A1 (sv) |
HU (2) | HU222498B1 (sv) |
IE (1) | IE70601B1 (sv) |
IL (1) | IL101311A (sv) |
IS (1) | IS3825A (sv) |
MY (1) | MY108441A (sv) |
NO (1) | NO178227C (sv) |
NZ (1) | NZ242067A (sv) |
RO (1) | RO109193B1 (sv) |
RU (1) | RU2097378C1 (sv) |
SK (1) | SK279688B6 (sv) |
TW (1) | TW198011B (sv) |
UA (1) | UA39849C2 (sv) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
DE4127404A1 (de) | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
JPH08505391A (ja) * | 1992-12-30 | 1996-06-11 | スミスクライン・ビーチャム・コーポレイション | 化合物 |
US5750754A (en) * | 1993-03-29 | 1998-05-12 | Zeneca Limited | Heterocyclic compounds |
US5753659A (en) * | 1993-03-29 | 1998-05-19 | Zeneca Limited | Heterocyclic compouds |
DE69411900T2 (de) * | 1993-03-29 | 1998-12-10 | Zeneca Ltd., London | Heterozyklische derivate als plätchenaggregationsinhibitoren |
US5652242A (en) * | 1993-03-29 | 1997-07-29 | Zeneca Limited | Heterocyclic derivatives |
ZW4194A1 (en) * | 1993-03-29 | 1994-12-21 | Zeneca Ltd | Heterocyclic compounds |
HUT70045A (en) * | 1993-06-17 | 1995-09-28 | Takeda Chemical Industries Ltd | 2-piperazinone derivatives parmaceutical compositions containing them and process for producing them |
US5463011A (en) * | 1993-06-28 | 1995-10-31 | Zeneca Limited | Acid derivatives |
GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
GB9313285D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Acid derivatives |
CA2166075A1 (en) * | 1993-06-30 | 1995-01-12 | Yoshiharu Ikeda | Novel dipiperidine derivative |
US5523302A (en) * | 1993-11-24 | 1996-06-04 | The Du Pont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
US5446056A (en) * | 1993-11-24 | 1995-08-29 | The Du Pont Merck Pharmaceutical Company | Isoxazoline compounds useful as fibrinogen receptor antagonists |
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
SI0656348T1 (en) * | 1993-12-03 | 2000-08-31 | F. Hoffmann-La Roche Ag | Aceric acid derivatives as medicaments |
US5563158A (en) * | 1993-12-28 | 1996-10-08 | The Dupont Merck Pharmaceutical Company | Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists |
WO1996033982A1 (en) * | 1995-04-26 | 1996-10-31 | Takeda Chemical Industries, Ltd. | Piperazinones useful as inhibitors of platelet aggregation |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
NZ315677A (en) * | 1995-09-07 | 2000-02-28 | F | 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
DE10006453A1 (de) * | 2000-02-14 | 2001-08-16 | Bayer Ag | Piperidylcarbonsäuren als Integrinantagonisten |
US7163918B2 (en) * | 2000-08-22 | 2007-01-16 | New River Pharmaceuticals Inc. | Iodothyronine compositions |
US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
US20060014697A1 (en) * | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
EP1677783A2 (en) | 2003-10-08 | 2006-07-12 | Nicholas Piramal India Limited | Fibrinogen receptor antagonists and their use |
FR3027518B1 (fr) | 2014-10-24 | 2018-01-19 | Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic | Utilisation d'ester d'isosorbide et de derives n-acyles d'acides amines comme agent antivieillissement de la peau humaine |
FR3027599A1 (fr) | 2014-10-27 | 2016-04-29 | Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic | Utilisation d'ester de derives n-acyles d'acide amines et de polyols comme agent antivieillissement de la peau humaine |
CN105348147A (zh) * | 2015-10-08 | 2016-02-24 | 上海吉尔多肽有限公司 | 一种Nα-芴甲氧羰基-Nγ-叔丁氧羰基-L-2,4-二氨基丁酸的合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518088B1 (fr) * | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
CA1261335A (en) * | 1984-08-29 | 1989-09-26 | Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee | Ethylenediamine monoamide derivatives |
CA1328333C (en) * | 1988-03-04 | 1994-04-05 | Quirico Branca | Amino acid derivatives |
US5256645A (en) * | 1988-03-04 | 1993-10-26 | Hoffmann-La Roche Inc. | Amino acid derivatives |
US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
-
1992
- 1992-01-31 RU SU925010974A patent/RU2097378C1/ru not_active IP Right Cessation
- 1992-01-31 UA UA5010974A patent/UA39849C2/uk unknown
- 1992-02-20 TW TW081101239A patent/TW198011B/zh active
- 1992-02-21 CA CA002061661A patent/CA2061661A1/en not_active Abandoned
- 1992-03-16 DE DE59203619T patent/DE59203619D1/de not_active Expired - Fee Related
- 1992-03-16 AT AT92104474T patent/ATE127800T1/de not_active IP Right Cessation
- 1992-03-16 ES ES92104474T patent/ES2078570T3/es not_active Expired - Lifetime
- 1992-03-16 EP EP92104474A patent/EP0505868B1/de not_active Expired - Lifetime
- 1992-03-16 DK DK92104474.9T patent/DK0505868T3/da not_active Application Discontinuation
- 1992-03-18 FI FI921163A patent/FI105024B/sv not_active IP Right Cessation
- 1992-03-18 HU HU9200899A patent/HU222498B1/hu not_active IP Right Cessation
- 1992-03-19 US US07/854,135 patent/US5378712A/en not_active Expired - Fee Related
- 1992-03-20 NZ NZ242067A patent/NZ242067A/en not_active IP Right Cessation
- 1992-03-20 AU AU13081/92A patent/AU659629B2/en not_active Ceased
- 1992-03-20 IL IL10131192A patent/IL101311A/en active IP Right Grant
- 1992-03-23 JP JP4095786A patent/JPH06102640B2/ja not_active Expired - Fee Related
- 1992-03-23 RO RO92-200384A patent/RO109193B1/ro unknown
- 1992-03-24 IS IS3825A patent/IS3825A/is unknown
- 1992-03-24 MY MYPI92000494A patent/MY108441A/en unknown
- 1992-03-25 DZ DZ920029A patent/DZ1566A1/fr active
- 1992-03-25 SK SK893-92A patent/SK279688B6/sk unknown
- 1992-03-25 CZ CS92893A patent/CZ283508B6/cs not_active IP Right Cessation
- 1992-03-25 KR KR1019920004818A patent/KR100254757B1/ko not_active IP Right Cessation
- 1992-03-25 IE IE920953A patent/IE70601B1/en not_active IP Right Cessation
- 1992-03-25 NO NO921169A patent/NO178227C/no unknown
-
1994
- 1994-03-01 BG BG098633A patent/BG60796B2/bg unknown
- 1994-09-21 US US08/310,016 patent/US5658928A/en not_active Expired - Fee Related
- 1994-11-23 EE EE9400189A patent/EE02982B1/xx not_active IP Right Cessation
-
1995
- 1995-05-25 US US08/452,614 patent/US5747522A/en not_active Expired - Fee Related
- 1995-05-25 US US08/452,616 patent/US5670515A/en not_active Expired - Fee Related
- 1995-06-16 HU HU95P/P00232P patent/HU211978A9/hu unknown
- 1995-12-12 GR GR950403503T patent/GR3018374T3/el unknown
-
1998
- 1998-04-17 HK HK98103232A patent/HK1003997A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI105024B (sv) | Förfarande för framställning av terapeutiskt användbara N-(amidinobensoyl- eller amidinopyridylkarbonyl)-alfa-aminosyraderivat | |
US5430024A (en) | Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation | |
DK171888B1 (da) | Benzoe- og phenyleddikesyreamidderivater, farmaceutiske præparater indeholdende forbindelserne, anvendelse af forbindelserne, samt mellemprodukter | |
EP0445796B1 (de) | Peptidbindungen enthaltende Essigsäurederivate | |
ES2209337T3 (es) | Agentes antitromboticos. | |
IE912344A1 (en) | Guanidines | |
DE60215368T2 (de) | Pyranderivate als inhibitoren von ace und nep | |
US5250517A (en) | Renin inhibiting compounds | |
NZ226395A (en) | Renin-inhibiting amino acid derivatives and pharmaceutical compositions | |
US5140011A (en) | Amino acid derivatives which have renin inhibiting activity | |
JP4927566B2 (ja) | Par−2アゴニスト | |
US20090012006A1 (en) | Par-2 Antagonists | |
US5545658A (en) | Amino acid derivatives | |
SI9210295A (sl) | Derivati n-acil-alfa-aminokislin | |
LT3681B (en) | N-acyl-alpha-amino acid derivatives, method for producting thereof,pharmaceutical compositions and preparing them | |
FI105474B (sv) | Aminer och alkoholer, som används som mellanprodukter | |
CZ63994A3 (cs) | Derivát heterocyklického sulfonamídu a farmaceutický prostředek, který ho obsahuje | |
LV10424B (en) | N-acyl-alfa-aminoacid derivatives, method for preparation thereof, pharmaceutical remedies, method for production thereofde thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |